|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangibles | |||||
| Loss on disposal of fixed assets, net | |||||
| Foreign exchange loss | |||||
| Provision (benefit) for credit losses - financing receivables | |||||
| Provision for credit losses - accounts receivable | |||||
| Provision for obsolete inventory | |||||
| Amortization of lease right-of-use assets | |||||
| Stock-based compensation expense on restricted stock awards | |||||
| Deferred income taxes | |||||
| Increase in cash surrender value of life insurance | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease (increase) in accounts receivable | |||||
| Accounts receivable | |||||
| Financing receivables | |||||
| Inventories | |||||
| Decrease in refundable income taxes | |||||
| Increase in operating lease right-of-use assets | |||||
| Other assets | |||||
| Decrease in investment in lease | |||||
| Decrease in long-term receivable | |||||
| Accounts payable and accrued expenses | |||||
| Decrease in interest payable | |||||
| Operating lease liabilities | |||||
| Deferred revenue and contract liabilities | |||||
| Pension and retirement plans liabilities | |||||
| Income taxes payable | |||||
| Other noncurrent liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Life insurance premiums paid | |||||
| Purchase of held-to-maturity investments | |||||
| Proceeds from maturities of held-to-maturity investments | |||||
| Proceeds from corporate life insurance owned policy | |||||
| Proceeds from sales of property, equipment, and improvements | |||||
| Additions of intangible assets | |||||
| Purchases of property, equipment and improvements | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Dividends paid | |||||
| Net repayments under line-of-credit agreement | |||||
| Repayments on note payable | |||||
| Principal payments on finance leases | |||||
| Repurchases of common stock | |||||
| Proceeds from issuance of shares under equity compensation plans | |||||
| Net cash used in financing activities | |||||
| Effects of exchange rate on cash, net | |||||
| Net (decrease) increase in Cash and cash equivalents | |||||
| Cash and cash equivalents beginning of period | |||||
| Cash and cash equivalents end of period | |||||
| Supplementary cash flow information: | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Supplementary non-cash financing activities: | |||||
| Obtaining a right-of-use asset in exchange for a lease liability | |||||
| Customer financing for inventory sold (see Note 5 Financing receivables, net for details) | |||||
| Vendor financing for inventory purchased (see Note 8 Accounts payable and accrued expenses, and Other noncurrent liabilities for details) | |||||
Loading...